| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.638 | 24.785 | 21.667 | 15.159 | 21.084 | 9.982 | 3.605 | 0 | 0 | 0 |
| Total Income - EUR | 30.808 | 32.877 | 34.380 | 46.102 | 22.482 | 10.462 | 3.606 | 0 | 951 | 0 |
| Total Expenses - EUR | 28.572 | 30.247 | 39.414 | 13.602 | 7.960 | 7.666 | 4.253 | 842 | 895 | 120 |
| Gross Profit/Loss - EUR | 2.236 | 2.629 | -5.034 | 32.500 | 14.522 | 2.796 | -647 | -842 | 56 | -120 |
| Net Profit/Loss - EUR | 1.312 | 2.302 | -5.378 | 32.039 | 13.847 | 2.481 | -755 | -842 | 37 | -120 |
| Employees | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rofarma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 23.386 | 18.688 | 0 | 12.363 | 17.660 | 18.362 | 720 | 7.813 | 7.789 | 7.746 |
| Current Assets | 41.317 | 35.170 | 33.163 | 25.622 | 33.043 | 29.566 | 20.615 | 5.165 | 4.995 | 4.986 |
| Inventories | 9.680 | 13.030 | 12.512 | 8.131 | 7.190 | 7.054 | 5.355 | 3.756 | 3.744 | 3.723 |
| Receivables | 28.166 | 20.928 | 19.175 | 15.674 | 14.658 | 13.809 | 14.305 | 1.402 | 1.249 | 1.261 |
| Cash | 3.472 | 1.213 | 1.475 | 1.818 | 11.196 | 8.703 | 954 | 8 | 2 | 2 |
| Shareholders Funds | -17.097 | -23.513 | -28.493 | 4.863 | 20.723 | 22.578 | 4.601 | 3.773 | 3.799 | 3.658 |
| Social Capital | 1.462 | 1.447 | 1.423 | 1.397 | 3.477 | 3.411 | 3.335 | 3.346 | 3.336 | 3.317 |
| Debts | 81.868 | 77.370 | 61.656 | 33.123 | 29.989 | 27.273 | 23.985 | 9.205 | 8.985 | 9.074 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Rofarma Srl